SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

Christopher Dilts — Bloomberg via Getty Images

19

Walgreens Boots Alliance

WBA

Walgreens Boots Alliance has not looked healthy lately. Its partnerships with scandal-plagued Silicon Valley unicorn Theranos and controversial drug company Valeant have led to countless embarrassing headlines. Its acquisition of smaller rival Rite Aid may force it to sell off more drugstores than it really wants to. All the while, the company is still working to integrate the Alliance Boots acquisition last year and the turnover of most of its c-level executives. Still, Walgreens size gives it enormous clout with drugmakers, and the Boots products have been a big shot in the arm for its beauty business, allowing it to fend off CVS’ big push in that area. And its generic drug distribution contract with AmerisourceBergen has allowed it keep costs in check by streamlining how its gets its supply of drugs.

CEO

Stefano Pessina

Sector

Food and Drug Stores

Industry

Food and Drug Stores

HQ Location

Deerfield, IL

Years on Fortune 500 List

22

Employees

302,500

Figures are for fiscal year ended Aug. 31, 2015., Reorganized as a holding company after acquiring the remaining 55% of Alliance Boots (Switzerland), Dec. 31, 2014. Prior year's figures are for Walgreen, now a subsidiary of the company.
Walgreens Boots Alliance is also featured in these fortune lists
Key Financials (last fiscal year)
$ millions% change
Revenues ($M)$103,44435.4%
Profits ($M)$4,220118.4%
Assets ($M)$68,782
Total Stockholder Equity ($M)$30,861
Market Value — as of March 31, 2016 ($M)$90,874
Profit Ratios
Profit as % of Revenues4.1%
Profits as % of Assets6.1%
Profits as % of Stockholder Equity13.7%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)4.00
EPS % Change (from 2014)100.0%
EPS % Change (5 year annual rate)13.5%
EPS % Change (10 year annual rate)10.2%
Total Return
Total Return to Investors (2015)13.6%
Total Return to Investors (5 year, annualized)19.5%
Total Return to Investors (10 year, annualized)8.6%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Walgreens Boots Alliance

CVS Stores Are Failing to Bring In Customers

Profit is way down as fewer shoppers are coming in.

Read More →
Your Local CVS Drugstore Is About to Look Very Different

There will be a lot more focus on beauty and health

Read More →
Retail CEOs Are Heading to Washington to Plead Case Against Import Tax

The group of eight retail bosses will meet with members of Congress on Wednesday, sources said.

Read More →

Videos about Walgreens Boots Alliance

Walgreen, Rite Aid, Pfizer and Allergan: Behind the merger mania

Fortune’s Andrew Nusca and Alan Murray discuss what’s driving this week’s big business deals.

Read More →